DE602004022704D1 - 4-phenylpiperidinderivate als renininhibitoren - Google Patents
4-phenylpiperidinderivate als renininhibitorenInfo
- Publication number
- DE602004022704D1 DE602004022704D1 DE602004022704T DE602004022704T DE602004022704D1 DE 602004022704 D1 DE602004022704 D1 DE 602004022704D1 DE 602004022704 T DE602004022704 T DE 602004022704T DE 602004022704 T DE602004022704 T DE 602004022704T DE 602004022704 D1 DE602004022704 D1 DE 602004022704D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- formula
- coronary syndrome
- fibrosis
- renininhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52537503P | 2003-11-26 | 2003-11-26 | |
| PCT/EP2004/013410 WO2005051911A1 (en) | 2003-11-26 | 2004-11-25 | 4-phenylpiperidine derivatives as renin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004022704D1 true DE602004022704D1 (de) | 2009-10-01 |
Family
ID=34632979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004022704T Expired - Lifetime DE602004022704D1 (de) | 2003-11-26 | 2004-11-25 | 4-phenylpiperidinderivate als renininhibitoren |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20070078164A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1689712B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4750712B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060120146A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1906163A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE440082T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004293177B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0416976A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2546264A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602004022704D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2332053T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1689712T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1689712E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2374228C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005051911A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004022704D1 (de) * | 2003-11-26 | 2009-10-01 | Novartis Ag | 4-phenylpiperidinderivate als renininhibitoren |
| CA2577084A1 (en) | 2004-08-25 | 2006-03-02 | Olivier Bezencon | Bicyclononene derivatives as renin inhibitors |
| RU2407523C2 (ru) * | 2004-10-08 | 2010-12-27 | Новартис Аг | Применение ингибиторов ренина для профилактики или лечения диастолической дисфункции или диастолической сердечной недостаточности |
| GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
| EP1707202A1 (de) * | 2005-03-31 | 2006-10-04 | Speedel Experimenta AG | Organische Verbindungen |
| GB0508992D0 (en) * | 2005-05-03 | 2005-06-08 | Novartis Ag | Organic compounds |
| AU2006253805A1 (en) | 2005-05-27 | 2006-12-07 | Actelion Pharmaceuticals Ltd. | Novel piperidine carboxylic acid amide derivatives |
| GB0514203D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
| JP5306821B2 (ja) * | 2005-12-30 | 2013-10-02 | ノバルティス アーゲー | レニン阻害剤としての3,5−置換ピペリジン化合物 |
| RU2415840C2 (ru) * | 2005-12-30 | 2011-04-10 | Новартис Аг | 3,5-замещенные пиперидины, как ингибиторы ренина |
| GB0611696D0 (en) * | 2006-06-13 | 2006-07-26 | Novartis Ag | Organic compounds |
| TW200821303A (en) * | 2006-08-08 | 2008-05-16 | Speedel Experimenta Ag | Organic compounds |
| WO2008074450A2 (en) * | 2006-12-20 | 2008-06-26 | Nicox S.A. | Non-peptidic renin inhibitors nitroderivatives |
| EP1987834A3 (en) * | 2007-02-13 | 2008-11-19 | Speedel Experimenta AG | Substituted piperidines as therapeutic compounds |
| EP1958634A3 (en) * | 2007-02-14 | 2008-09-24 | Speedel Experimenta AG | Substituted piperidines as inhibitors of beta-secretase, cathepsin D, plasmepsin II and/or HIV protease |
| NZ582098A (en) | 2007-06-25 | 2012-03-30 | Novartis Ag | N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4616088A (en) * | 1984-10-29 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitor |
| US5668151A (en) * | 1995-06-07 | 1997-09-16 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: piperidine derivatives |
| PL193686B1 (pl) * | 1995-09-07 | 2007-03-30 | Hoffmann La Roche | Pochodne piperydyny, środki lecznicze zawierającepochodne piperydyny, sposoby wytwarzania tych pochodnych oraz zastosowanie pochodnych |
| AU3818900A (en) | 1999-04-14 | 2000-11-02 | F. Hoffmann-La Roche Ag | Process for the preparation of substituted piperidines |
| US6376672B1 (en) | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
| US6197959B1 (en) | 1999-04-27 | 2001-03-06 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| WO2002076440A2 (en) | 2001-03-23 | 2002-10-03 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease with piperidin derivates |
| JP2004534017A (ja) | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | Baceのインヒビター |
| AU2003250858A1 (en) * | 2002-06-28 | 2004-01-19 | Novartis Ag | Use of organic compounds |
| US20040204455A1 (en) | 2003-04-10 | 2004-10-14 | Cody Wayne Livingston | Piperidine derivative rennin inhibitors |
| US20040214832A1 (en) | 2003-04-10 | 2004-10-28 | Cuiman Cai | Piperazine derivative renin inhibitors |
| DE602004022704D1 (de) * | 2003-11-26 | 2009-10-01 | Novartis Ag | 4-phenylpiperidinderivate als renininhibitoren |
-
2004
- 2004-11-25 DE DE602004022704T patent/DE602004022704D1/de not_active Expired - Lifetime
- 2004-11-25 WO PCT/EP2004/013410 patent/WO2005051911A1/en not_active Ceased
- 2004-11-25 CA CA002546264A patent/CA2546264A1/en not_active Abandoned
- 2004-11-25 BR BRPI0416976-0A patent/BRPI0416976A/pt not_active IP Right Cessation
- 2004-11-25 AT AT04798086T patent/ATE440082T1/de not_active IP Right Cessation
- 2004-11-25 PL PL04798086T patent/PL1689712T3/pl unknown
- 2004-11-25 CN CNA2004800409431A patent/CN1906163A/zh active Pending
- 2004-11-25 RU RU2006122637/04A patent/RU2374228C2/ru not_active IP Right Cessation
- 2004-11-25 US US10/580,296 patent/US20070078164A1/en not_active Abandoned
- 2004-11-25 EP EP04798086A patent/EP1689712B1/en not_active Expired - Lifetime
- 2004-11-25 AU AU2004293177A patent/AU2004293177B2/en not_active Ceased
- 2004-11-25 KR KR1020067010229A patent/KR20060120146A/ko not_active Ceased
- 2004-11-25 JP JP2006540386A patent/JP4750712B2/ja not_active Expired - Fee Related
- 2004-11-25 ES ES04798086T patent/ES2332053T3/es not_active Expired - Lifetime
- 2004-11-25 PT PT04798086T patent/PT1689712E/pt unknown
-
2008
- 2008-06-27 US US12/163,038 patent/US7754727B2/en not_active Expired - Fee Related
-
2010
- 2010-05-28 US US12/789,892 patent/US8362040B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20100240679A1 (en) | 2010-09-23 |
| RU2006122637A (ru) | 2008-01-27 |
| JP4750712B2 (ja) | 2011-08-17 |
| EP1689712A1 (en) | 2006-08-16 |
| PT1689712E (pt) | 2009-11-25 |
| ES2332053T3 (es) | 2010-01-25 |
| CN1906163A (zh) | 2007-01-31 |
| BRPI0416976A (pt) | 2007-02-21 |
| KR20060120146A (ko) | 2006-11-24 |
| US8362040B2 (en) | 2013-01-29 |
| EP1689712B1 (en) | 2009-08-19 |
| CA2546264A1 (en) | 2005-06-09 |
| PL1689712T3 (pl) | 2010-01-29 |
| JP2007512282A (ja) | 2007-05-17 |
| US20070078164A1 (en) | 2007-04-05 |
| WO2005051911A1 (en) | 2005-06-09 |
| RU2374228C2 (ru) | 2009-11-27 |
| US7754727B2 (en) | 2010-07-13 |
| AU2004293177A1 (en) | 2005-06-09 |
| US20080269255A1 (en) | 2008-10-30 |
| AU2004293177B2 (en) | 2008-10-23 |
| ATE440082T1 (de) | 2009-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005051895A8 (en) | Organic compounds | |
| ATE440082T1 (de) | 4-phenylpiperidinderivate als renininhibitoren | |
| WO2004052855A3 (en) | Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| WO2004052854A3 (en) | Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| JP2013515000A (ja) | 血漿カリクレインの阻害薬のプロドラッグ | |
| NO20055246L (no) | Heteroaromatisk pentasyklisk forbindelse og medisinsk anvendelse derav | |
| WO2006094187A3 (en) | Phthalazine, aza- and diaza-phthalazine compounds and methods of use | |
| DE50306845D1 (de) | Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide | |
| DE10393825D2 (de) | Hemmung der Proteinkinase C Alpha zur Behandlung von Diabetes mellitus und kardiovaskulärer Erkrankungen | |
| NO20050184L (no) | Nye benzimidazolderivater | |
| CY1108252T1 (el) | Χρηση παραγωγων μεθυλενο αμιδης στις καρδιαγγειακες διαταραχες | |
| TR200103067T2 (tr) | Renin inhibitörleri | |
| NO20070148L (no) | Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen | |
| CY1117790T1 (el) | Ενωσεις αναστολεα 11-βητα-υδροξυστεροειδους αφυδρογονασης τυπου 1 | |
| ATE442354T1 (de) | Pyrrolidinderivate als oxytocin antagonisten | |
| WO2007045551A3 (en) | Renin inhibitors nitroderivatives | |
| WO2003099822A3 (en) | 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof | |
| WO2008097953A3 (en) | Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| NO20034412D0 (no) | Merkaptoacetylamidderivater, fremgangsmåte for deres fremstilling og deresanvendelse | |
| IL204259A (en) | Use of resburicase to prepare a drug to treat or prevent heart disease or heart problems caused by previous events or blockage of blood flow to the heart | |
| WO2008097897A3 (en) | Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |